Search Content

Matching Items (2)

Electrospinning Stimuli-Responsive Fibers at the Nanoscale as Functional Drug Delivery Mats

Description

The objective of this research is to create biodegradable mats with tunable characteristics such as fiber diameter and surface area. The drug delivery mats enable spatially controlled delivery of disease-specific therapeutics. Using a large electric potential to draw fibers from a solution flowing at a specific rate, the polymer fibers reach a grounded target several inches away. The biodegradable polymer used in this study was poly(lactic acid-co-glycolic acid) (PLGA). PLGA solutions ranging from 0.5 to 27 wt.% were prepared by dissolving the block copolymer in a solvent mixture containing tetrahydrofuran (THF) and dimethylformamide (DMF) at a 3:1 weight ratio. They were then electrospun at needle-to-target distances of 7, 14, and 18 cm and rates ranging from 0.8 to 4 mL/h. The range of voltage used was between 8 – 15 kV, which was based on the observation of the formation of a Taylor cone, largely affected by on the environment and weather (e.g., temperature and humidity in the lab). A 27 wt.% PLGA solution, electrospun at 1 mL/h at a voltage of 11.25 kV and needle-to-target distance of 14 cm produced uniform fibers with an average fiber diameter of 0.985 m. All other parameters outside the range given created beaded fibers. In addition, solution rheology was performed on some of the PLGA solution to measure viscosity, which is directly correlated to the fiber diameter of the electrospun mats. Observing the impact of solvent on fiber spinning and fiber diameter brings about many positive results in developing fully characterized and well-understood fibrous mats for drug delivery. The nanoscale fibers will be used as drug delivery mats and, therefore, the biodegradation kinetics of the polymers will be studied. Next, parameters of the polymers as well as the polymeric mats will be correlated to the degradation-mediated release of small molecule therapeutics (e.g., peptides, drugs, etc.) such that time-resolved dosing profiles can be created.

ContributorsLent, Madeline (Author) / Green, Matthew (Thesis director) / Holloway, Julianne (Committee member) / Chemical Engineering Program (Contributor) / Barrett, The Honors College (Contributor)

Created2016-12

Developing a Polymer for Treatment of Basal Cell Carcinoma

Description

This analysis explores what the time needed to harden, and time needed to degrade is of a PLGA bead, as well as whether the size of the needle injecting the bead and the addition of a drug (Vismodegib) may affect these variables. Polymer degradation and hardening are critical to understand for the polymer’s use in clinical settings, as these factors help determine the patients’ and healthcare providers’ use of the drug and estimated treatment time. Based on the literature, it is expected that the natural logarithmic polymer mass degradation forms a linear relationship to time. Polymer hardening was tested by taking video recordings of gelatin plates as they are injected with microneedles and performing RGB analysis on the polymer “beads” created. Our results for the polymer degradation experiments showed that the polymer hardened for all solutions and trials within approximately 1 minute, presenting a small amount of time in which the patient would have to remain motionless in the affected area. Both polymer bead size and drug concentration may have had a modest impact on the hardening time experiments, while bead size may affect the time required for the polymer to degrade. Based on the results, the polymer degradation is expected to last multiple weeks, which may allow for the polymer to be used as a long-term drug delivery system in treatment of basal cell carcinoma.

ContributorsEltze, Maren Caterina (Author) / Vernon, Brent (Thesis director) / Buneo, Christopher (Committee member) / Harrington Bioengineering Program (Contributor) / School of International Letters and Cultures (Contributor) / Barrett, The Honors College (Contributor)

Created2021-05